Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Spindletop Capital is a healthcare-focused investment firm based in Austin, Texas. Founded with a heritage rooted in family office investments, the firm specializes in commercial stage and profitable healthcare companies. Spindletop Capital emphasizes the alignment of interests with stakeholders, aiming to build transformational healthcare businesses through partnerships with exceptional leaders.
The firm currently manages a portfolio of seven notable companies and operates with a growth equity investment strategy. Spindletop Capital leverages its extensive network and expertise in the healthcare sector to provide strategic guidance and operational support to enhance performance and growth. The firm is committed to maximizing risk-adjusted returns in the healthcare sector, focusing on businesses where technical, regulatory, and financial risks have been largely mitigated.
Spindletop Capital's office is located at 3571 Far West Blvd. Suite 108, Austin, TX 78731. The firm has established itself as a key player in the healthcare investment landscape, utilizing its Texas roots to drive value beyond capital investment.
Spindletop Capital invests in expansion capital for commercial stage healthcare opportunities, specifically targeting sectors such as healthcare services and distribution, biopharma, and specialty pharmaceuticals. The firm seeks to maximize risk-adjusted returns by focusing on businesses that have already mitigated technical, regulatory, and financial risks. This approach allows Spindletop to partner with companies that are poised for growth and have a clear path to profitability.
Geographically, Spindletop Capital operates primarily in North America, with a strong emphasis on the United States. The firm values partnerships with exceptional leaders and emphasizes the alignment of interests with stakeholders. By leveraging Texas resources and expertise, Spindletop Capital adds significant value beyond just capital, providing strategic guidance and operational support to its portfolio companies.
Spindletop Capital's portfolio includes seven notable companies that exemplify its focus on healthcare innovation:
These companies represent a diverse range of healthcare sectors, showcasing Spindletop Capital's commitment to investing in transformational healthcare solutions.
Dr. Evan Melrose: Managing Director with extensive experience in healthcare investments and a background in clinical practice.
Steve Whitlock: Managing Director who has led multiple successful investments in the healthcare sector.
Dr. Kelly Huang: Managing Director with expertise in biopharma and healthcare services.
Shannon Rothschild: Managing Director focused on operational support and strategic guidance for portfolio companies.
Jim Henry: Managing Director with a strong background in healthcare investments and business development.
Dr. Robert McDonald: Operating Partner with a focus on enhancing portfolio company performance through operational excellence.
Stephen Hipp: Managing Director (In Memoriam 1967 - 2023), known for his contributions to healthcare investment strategies.
To pitch to Spindletop Capital, founders should send an email to deals@spindletopcapital.com. The pitch deck should include a comprehensive overview of the business, market analysis, financial projections, and details on the leadership team. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
As of March 2023, Spindletop Capital continues to expand its portfolio in the healthcare sector, focusing on companies that align with its investment thesis. The firm has made significant investments in innovative healthcare solutions, enhancing its reputation as a key player in the industry.
Recent activity includes the addition of new companies to its portfolio, reflecting Spindletop's commitment to supporting transformational healthcare businesses. The firm remains active in seeking out opportunities that align with its focus on growth equity in the healthcare sector.
What are Spindletop Capital's investment criteria?
Spindletop Capital focuses on commercial stage and profitable healthcare companies. The firm seeks to invest in sectors such as healthcare services, biopharma, and specialty pharmaceuticals, emphasizing businesses where technical, regulatory, and financial risks have been largely mitigated.
How can I apply or pitch to Spindletop Capital?
Founders can pitch to Spindletop Capital by sending an email to deals@spindletopcapital.com. It is advisable to include a detailed business plan and financial projections in the pitch deck.
What makes Spindletop Capital different from other investors?
Spindletop Capital differentiates itself through its healthcare focus and its commitment to aligning interests with stakeholders. The firm leverages its Texas resources and expertise to provide strategic guidance and operational support to its portfolio companies.
What is the geographic scope of Spindletop Capital's investments?
The firm primarily invests in North America, with a strong emphasis on the United States, targeting healthcare companies that are positioned for growth.
What is Spindletop Capital's approach to post-investment involvement?
Spindletop Capital actively engages with its portfolio companies, providing operational support and strategic guidance to enhance performance and growth. The firm aims to build long-term partnerships with exceptional leaders in the healthcare sector.
What is the typical check size for investments made by Spindletop Capital?
While specific check sizes are not disclosed, Spindletop Capital focuses on expansion capital for commercial stage healthcare opportunities, indicating a preference for significant investments that support growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.